These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 12959311)

  • 1. Post-exercise reduction in blood pressure in hypertensive subjects: effects of angiotensin converting enzyme inhibition.
    Beaulieu M; Nadeau A; Lacourcière Y; Cléroux J
    Br J Clin Pharmacol; 1993 Oct; 36(4):331-8. PubMed ID: 12959311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of angiotensin antagonism with tasosartan on regional and systemic haemodynamics in hypertensive patients.
    Rhéaume C; Waib PH; Lacourcière Y; Cléroux J
    J Hypertens; 1998 Dec; 16(12 Pt 2):2085-9. PubMed ID: 9886901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the first dose response of fosinopril and captopril in congestive heart failure: a randomized, double-blind, placebo controlled study.
    Eryonucu B; Koldas L; Ayan F; Keser N; Sirmaci A
    Jpn Heart J; 2001 Mar; 42(2):185-91. PubMed ID: 11384079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of antihypertensive effects of once-a-day isradipine and fosinopril: a double-blind crossover study by means of ambulatory blood pressure monitoring.
    Perticone F; Pugliese F; Marcantonio AM; Cloro C; Maio R; Mattioli PL
    Clin Cardiol; 1995 Jul; 18(7):401-7. PubMed ID: 7554545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacodynamic effects of dual neutral endopeptidase-angiotensin-converting enzyme inhibition versus angiotensin-converting enzyme inhibition in humans.
    Massien C; Azizi M; Guyene TT; Vesterqvist O; Mangold B; Ménard J
    Clin Pharmacol Ther; 1999 Apr; 65(4):448-59. PubMed ID: 10223783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of fosinopril/hydrochlorothiazide combinations on ambulatory blood pressure profiles in hypertension. Fosinopril/Hydrochlorothiazide Investigators.
    Guthrie R; Reggi DR; Plesher MM; Saini RK; Battikha JP
    Am J Hypertens; 1996 Apr; 9(4 Pt 1):306-11. PubMed ID: 8722432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of the factorial design and quadratic response surface models to evaluate the fosinopril and hydrochlorothiazide combination therapy in hypertension.
    Pool JL; Cushman WC; Saini RK; Nwachuku CE; Battikha JP
    Am J Hypertens; 1997 Jan; 10(1):117-23. PubMed ID: 9008256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ACE inhibition with spirapril improves diastolic function at rest independent of vasodilation during treatment with spirapril in mild to moderate hypertension.
    Petersen JR; Drabaek H; Gleerup G; Mehlsen J; Petersen LJ; Winther K
    Angiology; 1996 Mar; 47(3):233-40. PubMed ID: 8638865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of fosinopril on cardiac function in patients with hypertension. Radionuclide assessment of left ventricular systolic and diastolic performance.
    Zusman RM; Christensen DM; Higgins J; Boucher CA
    Am J Hypertens; 1992 Apr; 5(4 Pt 1):219-23. PubMed ID: 1534664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of angiotensin converting enzyme inhibitor on renal haemodynamics during mental stress.
    Schmieder RE; Schobel HP; Gatzka CE; Häuser W; Dominiak P; Mann JF; Luft FC
    J Hypertens; 1996 Oct; 14(10):1201-7. PubMed ID: 8906519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is the extrapolated adult dose of fosinopril safe and effective in treating hypertensive children?
    Li JS; Berezny K; Kilaru R; Hazan L; Portman R; Hogg R; Jenkins RD; Kanani P; Cottrill CM; Mattoo TK; Zharkova L; Kozlova L; Weisman I; Deitchman D; Califf RM
    Hypertension; 2004 Sep; 44(3):289-93. PubMed ID: 15262902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unchanged neurogenic vasoconstrictor response after exercise during angiotensin converting enzyme inhibition with fosinopril.
    Beaulieu M; Lacourcière Y; Cléroux J
    Am J Hypertens; 1994 Aug; 7(8):763-6. PubMed ID: 7986469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skeletal muscle angiotensin-converting enzyme and its relationship to blood pressure in primary hypertension and healthy elderly men.
    Reneland R; Haenni A; Andersson PE; Andrén B; Lithell H
    Blood Press; 1999; 8(1):16-22. PubMed ID: 10412878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of senile hypertension: the Fosinopril in Old Patients Study (FOPS).
    Vetter W
    Am J Hypertens; 1997 Oct; 10(10 Pt 2):255S-261S. PubMed ID: 9366282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effectiveness and tolerance of fosinopril in the treatment of arterial hypertension of mild and medium severity].
    Rosolová H; Cech J; Sefrna F
    Vnitr Lek; 2001 Dec; 47(12):834-9. PubMed ID: 11826546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of fosinopril on the blood pressure and lipid profile of patients undergoing heart transplantation.
    Almenar L; Osa A; Palencia M; Flores A; Sánchez E
    J Heart Lung Transplant; 1997 Apr; 16(4):454-9. PubMed ID: 9154957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fosenopril, an angiotensin-converting enzyme inhibitor, and propranolol: comparative effects at rest and exercise on blood pressure, hormonal variables, and plasma potassium in essential hypertension.
    Sullivan PA; Cervenka J; O'Connor DT; Dineen M
    Cardiovasc Drugs Ther; 1989 Mar; 3(1):57-62. PubMed ID: 2535052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of fosenopril, a once-daily angiotensin-converting enzyme inhibitor, on resting and exercise-induced changes of blood pressure, hormonal variables, and plasma potassium in essential hypertension.
    Sullivan PA; Dineen M; Cervenka J; O'Connor DT
    Am J Hypertens; 1988 Jul; 1(3 Pt 3):280S-283S. PubMed ID: 2970855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined inhibition of neutral endopeptidase and angiotensin-converting enzyme by sampatrilat in essential hypertension.
    Wallis EJ; Ramsay LE; Hettiarachchi J
    Clin Pharmacol Ther; 1998 Oct; 64(4):439-49. PubMed ID: 9797801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Add-on angiotensin receptor blockade with maximized ACE inhibition.
    Agarwal R
    Kidney Int; 2001 Jun; 59(6):2282-9. PubMed ID: 11380832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.